Detalhe da pesquisa
1.
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Lancet Oncol
; 23(4): 540-552, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358455
2.
Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer.
Anticancer Drugs
; 26(10): 1061-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26295868
3.
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.
J Clin Oncol
; 41(14): 2458-2466, 2023 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146426
4.
Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma.
Oncol Lett
; 21(6): 449, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33868487
5.
Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study.
Lung Cancer Manag
; 8(3): LMT15, 2019 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31807143
6.
Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.
Carcinogenesis
; 29(4): 762-5, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18281249
7.
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.
J Clin Oncol
; 33(34): 4007-14, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26324372
8.
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.
J Clin Oncol
; 30(17): 2046-54, 2012 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22547592
9.
Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population.
PLoS One
; 6(9): e25057, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21966413
10.
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
J Clin Oncol
; 27(28): 4787-92, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19720897
11.
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
J Clin Oncol
; 26(21): 3543-51, 2008 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18506025
12.
Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.
J Clin Oncol
; 25(12): 1545-52, 2007 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17442998
13.
Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer.
Breast Cancer Res Treat
; 95(2): 141-5, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16267612